 | • レポートコード：GIR201107030 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ポリオワクチンの世界市場を調査対象にし、ポリオワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別分析（パブリック、プライベート）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Sanofi、Bio-Med、Serum Institute、GSK、Panacea Biotec Ltd、Bibcol、IMBCA、Tiantan Biological、Halfkin Bio-Pharmaceuticals ・メーカー別販売量、売上、市場シェア ・ポリオワクチンの地域別市場分析 ・ポリオワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ポリオワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ポリオワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ポリオワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ポリオワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ポリオワクチンの種類別市場規模2015-2020：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） ・ポリオワクチンの用途別市場規模2015-2020：パブリック、プライベート ・ポリオワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Polio Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 1695.4 million by 2025, from USD 1391 million in 2019.
Market segmentation
Polio Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Polio Vaccine market has been segmented into
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
By Application, Polio Vaccine has been segmented into:
Public
Private
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Polio Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Polio Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Polio Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Polio Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Polio Vaccine Market Share Analysis
Polio Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Polio Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Polio Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Polio Vaccine are:
Sanofi
Bio-Med
Serum Institute
GSK
Panacea Biotec Ltd
Bibcol
IMBCA
Tiantan Biological
Halfkin Bio-Pharmaceuticals
Among other players domestic and global, Polio Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polio Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polio Vaccine, with price, sales, revenue and global market share of Polio Vaccine in 2018 and 2019.
Chapter 3, the Polio Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polio Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Polio Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Polio Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polio Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Polio Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Polio Vaccine Market
1.4.1 Global Polio Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Med
2.2.1 Bio-Med Details
2.2.2 Bio-Med Major Business
2.2.3 Bio-Med SWOT Analysis
2.2.4 Bio-Med Product and Services
2.2.5 Bio-Med Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Serum Institute
2.3.1 Serum Institute Details
2.3.2 Serum Institute Major Business
2.3.3 Serum Institute SWOT Analysis
2.3.4 Serum Institute Product and Services
2.3.5 Serum Institute Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Panacea Biotec Ltd
2.5.1 Panacea Biotec Ltd Details
2.5.2 Panacea Biotec Ltd Major Business
2.5.3 Panacea Biotec Ltd SWOT Analysis
2.5.4 Panacea Biotec Ltd Product and Services
2.5.5 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bibcol
2.6.1 Bibcol Details
2.6.2 Bibcol Major Business
2.6.3 Bibcol Product and Services
2.6.4 Bibcol Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 IMBCA
2.7.1 IMBCA Details
2.7.2 IMBCA Major Business
2.7.3 IMBCA Product and Services
2.7.4 IMBCA Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Tiantan Biological
2.8.1 Tiantan Biological Details
2.8.2 Tiantan Biological Major Business
2.8.3 Tiantan Biological Product and Services
2.8.4 Tiantan Biological Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Polio Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Polio Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Polio Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Polio Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Polio Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Polio Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Polio Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Polio Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Polio Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Polio Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Polio Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Polio Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Polio Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Polio Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Polio Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Polio Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Polio Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Polio Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Polio Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Polio Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Polio Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Polio Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Polio Vaccine Sales and Growth Rate (2015-2020)
6.4 France Polio Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Polio Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Polio Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Polio Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Polio Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Polio Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Polio Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Polio Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Polio Vaccine Sales and Growth Rate (2015-2020)
7.5 India Polio Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Polio Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Polio Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Polio Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Polio Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Polio Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Polio Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Polio Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Polio Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Polio Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Polio Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Polio Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Polio Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Polio Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Polio Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Polio Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Polio Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Polio Vaccine Price by Type (2015-2020)
11 Global Polio Vaccine Market Segment by Application
11.1 Global Polio Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Polio Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Polio Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Polio Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Polio Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Polio Vaccine Market Forecast (2021-2025)
12.2.2 Europe Polio Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Polio Vaccine Market Forecast (2021-2025)
12.2.4 South America Polio Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Polio Vaccine Market Forecast (2021-2025)
12.3 Polio Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Polio Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Polio Vaccine Market Share Forecast by Type (2021-2025)
12.4 Polio Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Polio Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Polio Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Polio Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Polio Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Polio Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Polio Vaccine Major Business
Table 10. Sanofi Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi SWOT Analysis
Table 12. Sanofi Polio Vaccine Product and Services
Table 13. Sanofi Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 15. Bio-Med Polio Vaccine Major Business
Table 16. Bio-Med Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Bio-Med SWOT Analysis
Table 18. Bio-Med Polio Vaccine Product and Services
Table 19. Bio-Med Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 21. Serum Institute Polio Vaccine Major Business
Table 22. Serum Institute Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. Serum Institute SWOT Analysis
Table 24. Serum Institute Polio Vaccine Product and Services
Table 25. Serum Institute Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. GSK Basic Information, Manufacturing Base and Competitors
Table 27. GSK Polio Vaccine Major Business
Table 28. GSK Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 29. GSK SWOT Analysis
Table 30. GSK Polio Vaccine Product and Services
Table 31. GSK Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 33. Panacea Biotec Ltd Polio Vaccine Major Business
Table 34. Panacea Biotec Ltd Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 35. Panacea Biotec Ltd SWOT Analysis
Table 36. Panacea Biotec Ltd Polio Vaccine Product and Services
Table 37. Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Bibcol Basic Information, Manufacturing Base and Competitors
Table 39. Bibcol Polio Vaccine Major Business
Table 40. Bibcol Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 41. Bibcol SWOT Analysis
Table 42. Bibcol Polio Vaccine Product and Services
Table 43. Bibcol Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. IMBCA Basic Information, Manufacturing Base and Competitors
Table 45. IMBCA Polio Vaccine Major Business
Table 46. IMBCA Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 47. IMBCA SWOT Analysis
Table 48. IMBCA Polio Vaccine Product and Services
Table 49. IMBCA Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 51. Tiantan Biological Polio Vaccine Major Business
Table 52. Tiantan Biological Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 53. Tiantan Biological SWOT Analysis
Table 54. Tiantan Biological Polio Vaccine Product and Services
Table 55. Tiantan Biological Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Halfkin Bio-Pharmaceuticals Polio Vaccine Major Business
Table 58. Halfkin Bio-Pharmaceuticals Polio Vaccine Total Revenue (USD Million) (2018-2019)
Table 59. Halfkin Bio-Pharmaceuticals SWOT Analysis
Table 60. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
Table 61. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Polio Vaccine Sales by Manufacturer (2018-2019) (M Doses)
Table 63. Global Polio Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Polio Vaccine Sales by Regions (2015-2020) (M Doses)
Table 65. Global Polio Vaccine Sales Market Share by Regions (2015-2020)
Table 66. Global Polio Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Polio Vaccine Sales by Countries (2015-2020) (M Doses)
Table 68. North America Polio Vaccine Sales Market Share by Countries (2015-2020)
Table 69. North America Polio Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Polio Vaccine Revenue Market Share by Countries (2015-2020)
Table 71. Europe Polio Vaccine Sales by Countries (2015-2020) (M Doses)
Table 72. Europe Polio Vaccine Sales Market Share by Countries (2015-2020)
Table 73. Europe Polio Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Polio Vaccine Sales by Regions (2015-2020) (M Doses)
Table 75. Asia-Pacific Polio Vaccine Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Polio Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Polio Vaccine Sales by Countries (2015-2020) (M Doses)
Table 78. South America Polio Vaccine Sales Market Share by Countries (2015-2020)
Table 79. South America Polio Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Polio Vaccine Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Polio Vaccine Sales by Countries (2015-2020) (M Doses)
Table 82. Middle East & Africa Polio Vaccine Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Polio Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Polio Vaccine Revenue Market Share by Countries (2015-2020)
Table 85. Global Polio Vaccine Sales by Type (2015-2020) (M Doses)
Table 86. Global Polio Vaccine Sales Share by Type (2015-2020)
Table 87. Global Polio Vaccine Revenue by Type (2015-2020) (USD Million)
Table 88. Global Polio Vaccine Revenue Share by Type (2015-2020)
Table 89. Global Polio Vaccine Sales by Application (2015-2020) (M Doses)
Table 90. Global Polio Vaccine Sales Share by Application (2015-2020)
Table 91. Global Polio Vaccine Sales Forecast by Regions (2021-2025) (M Doses)
Table 92. Global Polio Vaccine Market Share Forecast by Regions (2021-2025)
Table 93. Global Polio Vaccine Sales Forecast by Type (2021-2025) (M Doses)
Table 94. Global Polio Vaccine Market Share Forecast by Type (2021-2025)
Table 95. Global Polio Vaccine Sales Forecast by Application (2021-2025)
Table 96. Global Polio Vaccine Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Polio Vaccine Picture
Figure 2. Global Sales Market Share of Polio Vaccine by Type in 2019
Figure 3. Inactivated Polio Vaccine (IPV) Picture
Figure 4. Oral Polio Vaccine (OPV) Picture
Figure 5. Polio Vaccine Sales Market Share by Application in 2019
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Polio Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Polio Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Polio Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Polio Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Polio Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Polio Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Polio Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 34. Global Polio Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Polio Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Polio Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Polio Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Polio Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Polio Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Polio Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Polio Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Polio Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Polio Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Polio Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Polio Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Polio Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 48. Canada Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 49. Mexico Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 50. Europe Polio Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Polio Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Polio Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 54. UK Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 55. France Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 56. Russia Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 57. Italy Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 58. Asia-Pacific Polio Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Polio Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Polio Vaccine Revenue Market Share by Regions 2019
Figure 61. China Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 62. Japan Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 63. Korea Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 64. India Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 65. Southeast Asia Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 66. South America Polio Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Polio Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Polio Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 70. Argentina Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 71. Middle East and Africa Polio Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Polio Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Polio Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Polio Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 76. Egypt Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 77. Turkey Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 78. South Africa Polio Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 79. Global Polio Vaccine Sales and Growth Rate (2021-2025) (M Doses)
Figure 80. Global Polio Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Polio Vaccine Market Forecast (2021-2025) (M Doses)
Figure 82. Europe Sales Polio Vaccine Market Forecast (2021-2025) (M Doses)
Figure 83. Asia-Pacific Sales Polio Vaccine Market Forecast (2021-2025) (M Doses)
Figure 84. South America Sales Polio Vaccine Market Forecast (2021-2025) (M Doses)
Figure 85. Middle East & Africa Sales Polio Vaccine Market Forecast (2021-2025) (M Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
経口ポリオワクチン（OPV）の世界市場 2020年 Market Overview The global Oral Polio Vaccines (OPV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Polio Vaccines…- 鼻インフルエンザワクチンの世界市場 2020年 Market Overview The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 肺炎球菌ワクチンの世界市場 2020年 Market Overview The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 23価肺炎球菌多糖ワクチンの世界市場 2020年 Market Overview The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- ワクチン用中ホウケイ酸ガラス瓶の世界市場 2020年 Market Overview The Medium Borosilicate Glass Bottle for Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, va…